The Voxel Group, a network specialising in imaging diagnostics, will take over another debtor. On 7 November, a court decision on the acquisition of Scanix, a company operating in the same segment, became final and binding.
Eleven Scanix laboratories will join Voxel
The court proceedings concerned the approval of the arrangement in the sanitation proceedings. It resulted from Scanix’ debt to Voxel for the total amount of over PLN 31m. According to the arrangements, this amount was converted into share capital of Scanix, and Voxel acquired 81.7% of shares in it. Voxel plans to increase its stake in the company by purchasing shares from other shareholders.
Scanix, like Voxel, operates a network of imaging diagnostics laboratories. The company has 11 laboratories in five locations in the province of Silesia. It also has contracts with the National Health Fund for computed tomography (CT) and magnetic resonance imaging (MRI). In the first three quarters of 2019, Scanix’ revenues amounted to approximately PLN 13 million.
As we reported earlier, at the beginning of 2019. Voxel acquired Vito-Med, the operator of the hospital in Gliwice (specialising in the treatment of strokes). That transaction was also the result of an arrangement with the debtor.
Voxel performed more than 200,000 tests
In the first three quarters of 2019 Voxel performed 202,000 imaging diagnostic examinations, compared to 177,000 in the corresponding period of 2018. The company specialises in computed tomography (CT), magnetic resonance imaging (MRI) and PET, which in the first nine months of 2019 was performed to nearly 170,000 people.
At the end of September, Voxel had 14 CT, 18 MRI, 7 PET (of which 5 are active) and 4 SPECT (3 are active) laboratories.
In addition to Vito-Med, the Voxel Group also includes Voxel Inwestycje (formerly CDO Jelenia Gora, lease services for Voxel), Aleris (information technology and engineering company), Exira Gamma Knife (neuroradiosurgery) and Hannah (imaging diagnostics).